Yili Chuannig Biotechnology Co (SZSE:301301) Net Income (Continuing Operations) : ¥1,118 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Yili Chuannig Biotechnology Co's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was ¥353 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,118 Mil.

Yili Chuannig Biotechnology Co Net Income (Continuing Operations) Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Net Income (Continuing Operations) Chart

Yili Chuannig Biotechnology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

90.22

229.00

111.35

411.52

940.57

Yili Chuannig Biotechnology Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income (Continuing Operations)	Get a 7-Day Free Trial											175.45	215.42	249.28	300.42	352.63

Yili Chuannig Biotechnology Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,118 Mil.

Yili Chuannig Biotechnology Co (SZSE:301301) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Yili Chuannig Biotechnology Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000

Website

http://www.klcnsw.com

Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines